Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry
Organic Process Research & Development · 17.05.2024 · 28 (5) · 1546-1555
DOI: 10.1021/acs.oprd.3c00164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 24.08.2023. Verfasst von Sean M. Kelly und 13 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kelly, S. M., Lebl, R., Malig, T. C., Bass, T. M., Kummli, D., Kaldre, D., Orcel, U., Tröndlin, L., Linder, D., Sedelmeier, J., Bachmann, S., Han, C., Zhang, H., & Gosselin, F. (2024). Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry. Organic Process Research & Development, 28(5), 1546-1555. https://doi.org/10.1021/acs.oprd.3c00164
Vancouver
Kelly SM, Lebl R, Malig TC, Bass TM, Kummli D, Kaldre D, et al. Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry. Organic Process Research & Development. 2024;28(5):1546-1555. doi:10.1021/acs.oprd.3c00164
BibTeX
@article{Kelly2024,
author = {Kelly, Sean M. and Lebl, René and Malig, Thomas C. and Bass, Thomas M. and Kummli, Dominique and Kaldre, Dainis and Orcel, Ugo and Tröndlin, Lars and Linder, David and Sedelmeier, Joerg and Bachmann, Stephan and Han, Chong and Zhang, Haiming and Gosselin, Francis},
title = {Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry},
journal = {Organic Process Research & Development},
year = {2024},
volume = {28},
number = {5},
pages = {1546--1555},
doi = {10.1021/acs.oprd.3c00164}
}
EUVIMED